Articles tagged with Enzyme Activation
Researchers have developed an innovative antibody-based enzyme switch called 'Switchbody', which is activated upon antigen binding. The switch's mechanism relies on a 'trap-and-release' process, offering new opportunities in diagnostics and therapeutics.
Researchers have elucidated the final step in the biosynthesis of iridoids, a widespread class of plant secondary metabolites with defense and medicinal properties. The discovery of an enzyme catalyzing cyclisation to nepetalactol paves the way for future biotechnological production of these compounds.
Researchers at POSTECH and Korea Brain Research Institute unveil NeuO's mechanism of selective neuron staining through PAK6 kinase phosphorylation. This breakthrough opens path for precise tracking and study of living neurons in brain.
Salk Institute and UC San Diego researchers captured the first-of-its-kind video of dynein-Lis1 protein interaction, revealing 16 detailed shapes that support designing therapeutics to restore dynein and Lis1 function. The insights gained from this movie will help identify precise locations where drugs can interact with the proteins.
Researchers have identified ALPK2 as a potential therapeutic target for treating heart failure with preserved ejection function (HFpEF). The enzyme is believed to prevent stiff heart conditions through regulating the TPM1 gene. This discovery offers new hope for developing treatment options targeting ALPK2.
A KAIST research team identified core gene expression networks regulated by proteins that drive phenomena such as cancer development and tissue differentiation. The study revealed that IPMK acts as a critical transcriptional activator in these networks, enhancing SRF's protein activity.
A study reveals that protein kinase A promotes wakefulness, while protein phosphatase 1 and calcineurin promote sleep in mammals. The balance between sleep and wakefulness is regulated by multiple enzymes, including PKA, PP1, and calcineurin.
A newly developed compound, MOD06051, targets neutrophils and reduces harmful inflammation in rat models. This approach differs from current treatments that may have broader immunosuppressive effects, offering a safer alternative.
Research suggests that altered lipid signaling in brain cells contributes to mental disorders, with specific inhibitors showing promise in rebalancing this mechanism. The study found similar changes in both human patients and healthy relatives, as well as mice with genetic disorders, opening up new treatment opportunities.
LMU researchers identified key enzymes involved in recognizing foreign RNA for TLR7 activation, including RNase T2 and PLD exonucleases. These findings provide important insights into the complex activation mechanism of TLR7, which plays a crucial role in defending against viruses.
A new research project, PHOTOZYME, aims to develop photobiocatalytic tools to convert basic chemicals into chiral molecules. The project combines biocatalysis, photochemistry, and directed evolution to create sustainable molecular synthesis.
Researchers discovered that plant immune proteins condense into droplets to become activated and protect against infections. Phase separation plays a crucial role in the activation of TIR domain proteins, a class of important immune receptors.
A recent study by Tokyo University of Science researchers has uncovered the mechanisms by which plants regulate the production of reactive oxygen species (ROS). The findings, published in Physiologia Plantarum, reveal that ROS-generating enzymes are activated through two conserved mechanisms involving calcium ions and phosphorylation, ...
Researchers at the CNIC in Madrid have discovered a connection between stress kinases and the development of ventricular fibrillation. The study found that activation of these enzymes alters the electrical properties of cardiomyocytes, triggering arrhythmias.
Researchers at EMBL Grenoble have obtained the first structure of p38α being activated by MKK6, opening up new directions for developing drugs to stop cytokine storms. The inflammatory response is triggered by a series of kinases, and inactivating p38α could prevent inflammation from occurring.
Researchers at Nagoya University have developed an enzyme that can convert methane into methanol at room temperature in water. This technology has the potential to reduce the carbon footprint of natural gas and could be used to convert other hydrocarbons, offering a low-energy and environmentally friendly solution.
A study published in Proceedings of the National Academy of Sciences successfully reversed hearing loss in mice by activating a defective gene. The researchers found that introducing a special enzyme at a young age significantly improved hearing, with positive effects becoming less potent with time.
Scientists at the University of Ottawa have engineered an enzyme that can specifically cut small, non-coding RNAs, shedding light on their functions and paving the way for potential therapeutic applications. The new enzyme could be a powerful tool for studying these important RNA species.
Researchers at the University of Virginia have identified a promising approach to delay aging by detoxifying glycerol and glyceraldehyde, harmful by-products of fat. By activating an enzyme called AMAR, they found that microscopic worms lived longer and healthier lives, and similar effects were seen in other lab models.
A study by researchers at TUM found that gut bacteria play a crucial role in liver regeneration. The microbiome produces short-chain fatty acids, which are essential for liver cell growth and division. In mice treated with antibiotics, liver regeneration was delayed or not possible, but a
Researchers reveal Akt2's role in insulin-regulated metabolism, initiating energy production and nucleic acid synthesis. The study provides new insights into metabolic disorders like diabetes, paving the way for targeted therapeutics.
A study published in Science reveals that three faulty genes fail to regulate the immune system's response to SARS-CoV-2, leading to inflammatory overload and multisystem inflammation syndrome in children (MIS-C). The findings provide a mechanistic explanation for Kawasaki disease-like symptoms in these patients.
A recent study at Ruhr-University Bochum found that interactive online teaching can increase students' physiological state of arousal compared to passive online or face-to-face teaching. Students in interactive online classes reported feeling more involved and attentive but also experienced increased anxiety.
A new study explores the relationship between fatty acid amide hydrolase (FAAH) levels and heavy drinking patterns in young adults. Lower FAAH activity was associated with more severe drinking, increased cravings, and reduced sensitivity to alcohol's negative effects.
A team of researchers has developed a bioorthogonal molecular system that selectively transports nitrite ions to the endoplasmic reticulum, where they are released, triggering cell death in cancer cells. The system demonstrates synergistic effects with various cancer therapy drugs.
Researchers at the University of Bonn have identified a new signaling pathway that triggers inflammatory responses in the skin after UV damage. This pathway involves the activation of p38 molecularly modifying NLRP1, a critical switch for inflammation, and initiates the assembly of inflammasomes.
Researchers used live fluorescence imaging experiments to uncover the mechanism behind cell volume regulation, revealing that WNK kinases activate the 'switch' through phase separation. This discovery has implications for human health, particularly in relation to kidney function and salt-sensitive hypertension.
A study reveals that an ADAR1 gene mutation activates ZBP1 protein, leading to programmed cell death and inflammatory responses. This causes damage to organs like the kidneys and liver in genetically modified mouse models.
A Swiss-French team has identified a mechanism that could lead to the development of new therapies for acute myeloid leukaemia, a particularly dangerous form of cancer. The selective activation of AMPK triggers apoptosis in tumour cells by initiating the cell's stress response.
Researchers have identified RNase T2 as a central component in the innate immune response, which activates the receptor TLR8 when recognizing foreign RNA fragments. The enzyme is highly conserved across species and plays a crucial role in the activation of the receptor.
LMU researchers found that a central component of the innate immune response is activated by two short RNAs generated by site-specific cleavage of a precursor RNA molecule, mediated by the same enzyme RNase T2. The activation of one receptor, TLR8, is triggered by binding of these degradation products.
Researchers at Kyoto University developed a synthetic molecular code that can script gene activation, targeting histones and emulating the natural histone acetylation process. The code, called Bi-PIP, successfully activated a specific gene associated with central nervous system disorders in living cells.
Activation of glucokinase in the arcuate nucleus of rodents increased food intake and body mass, as well as preference for glucose. Inhibition of glucokinase decreased food consumption and glucose intake, indicating that glucokinase dysfunction may underlie glucose cravings.
Researchers created nanotweezers using DNA to manipulate enzymatic reactions with fine-grained control. The device separates an enzyme and a cofactor on separate arms of the instrument, allowing for external control of inhibition and activation.
Researchers at the University of North Carolina have identified a family of human genes known as Tousled-like kinases (TLKs) that play a key role in suppressing and activating herpesviruses. The discovery suggests that suppressing TLK enzymes may help prevent viral replication and reduce the risk of virus-associated cancers.
Mercury has been shown to activate phospholipase D enzyme in cells lining blood vessels, causing damage and contributing to vascular disorders. Chelation therapy and antioxidants have been found to suppress this activity, suggesting potential preventive measures against mercury-induced cardiovascular disease.
Researchers at Scripps Research Institute have discovered small molecule activators of botulinum neurotoxin (BoNT), which could minimize dosage and reduce resistance. The findings hold promise for increasing the clinical efficacy of BoNT, a toxin with a range of therapeutic uses.